_HOME | _RSS
_TRSSARTICLE
KRAS Mutations Predictive But Not Prognostic in Colorectal Cancer
Mittwoch, 02. Juli 2008, 05:27 Uhr - 5 Monate her - Presse spécialisée - Medscape family medicine
Another study has confirmed that KRAS mutations predict response to cetuximab in colorectal cancer, but shows that they are not prognostic. Medscape Medical News






